Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page
Unlocking the Emerging Opportunities in India’s Pharmaceutical Industry

Unlocking the Emerging Opportunities in India’s Pharmaceutical Industry

by Team Small News | May 22, 2025 | Aurobindo Pharma, Natco, Pharma, Piramal Pharma, Zydus

The Indian pharmaceutical sector has demonstrated robust growth over the past year, driven by a new trade agreement with the European Union that reduces tariffs on key drug exports. This agreement is expected to enhance India’s position as a global supplier of...

Aurobindo and MSN set to lose US patent protection for Nuplazid in August 2038

by Team Small News | May 22, 2025 | Aurobindo Pharma, Pharma

A recent US district court ruling has brought relief to Acadia Pharmaceuticals, the manufacturer of Nuplazid, a medication used to treat hallucinations and delusions associated with Parkinson’s disease psychosis. The court’s decision has upheld the...

Aurobindo Pharma subsidiary introduces leadership development initiative at Indian Management and Technology Institute Hyderabad

by Team Small News | May 17, 2025 | Aurobindo Pharma, Pharma

Aurobindo Pharma, a leading generic drug manufacturer, has launched a six-month post-graduation certification in leadership (CLP) program at the Institute of Management Technology, Hyderabad (IMT Hyderabad). The program, introduced through Aurobindo’s...

The Indian market for active pharmaceutical ingredients has experienced significant revenue generation.

by Team Small News | May 9, 2025 | Aurobindo Pharma, Cipla, Lupin, Pharma

The India Active Pharmaceutical Ingredients (API) market is expected to experience significant growth, with an estimated value of USD 14.81 billion in 2025 and a projected value of USD 25.23 billion by 2032, at a compound annual growth rate (CAGR) of 7.9%. This growth...

Aurobindo Pharma subsidiary receives US FDA approval for generic version of Bristol Myers Squibb’s cancer treatment

by Team Small News | Apr 24, 2025 | Aurobindo Pharma, Pharma

Aurobindo Pharma’s subsidiary, Eugia Pharma Specialities, has received final approval from the US Food and Drug Administration (FDA) to manufacture and market Dasatinib Tablets in various strengths. The approved product is bioequivalent and therapeutically...

Aurobindo Pharma secures FDA nod for generic version of Xarelto.

by Team Small News | Apr 14, 2025 | Aurobindo Pharma, Pharma

Aurobindo Pharma, a leading Indian pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for the generic equivalent of Xarelto (Rivaroxaban), a popular anticoagulant drug. The generic version, Rivaroxaban Tablets, will be used to...
« Older Entries

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress